Required Information [The following information applies to the questlons displayed below.] The December 31, 2024, unadjusted trial balance for the WolksteIn Drug Company is presented below. December 31 is the company's year-end reporting date. The following year-end adjusting entries are required: a. Depreclation expense for the year on the equipment is $11,400. b. Salarles at year-end should be accrued in the amount of $6,320. 2. Prepare an income statement for 2024 and a balance sheet as of December 31, 2024. 2. Prepare an income statement for 2024 and a balance sheet as of December 31,2024 . Complete this question by entering your answers in the tabs below. Prepare an income statement for 2024. Prepare a balance sheet as of December 31,2024. Note: Amounts to be deducted should be indicated with a minus sign